Pharmacological supervision

In accordance with Federal Law No. 61-FZ of April 12, 2010, on the Circulation of Medicinal Products:
«Subjects of circulation of medicines in the order established by the authorized Federal Executive body, must report to the authorized Federal Executive body about side effects, adverse reactions, serious adverse reactions, unexpected adverse reactions when using drugs …»

Why is it important to report adverse reactions?

• responsibility for the patient's health and safety;
• compliance with the requirements of international legislation and the legislation of the Russian Federation;
• for more information about the drug (may require changes to the instructions or withdrawal of the drug from the market);
• legal component - conduct of arbitration;
• safe products-reliable business

The purpose of such pharmacovigilance-is to identify, evaluate, understand, prevent adverse reactions or other problems associated with the use of drugs.

Any employee of the Company, received information about the adverse reaction to the drugs should IMMEDIATELY (within 24 hours!) to pass it on to the Responsible person for pharmacovigilance Luzhnetskaya Tatiana:

Form NOTICE about undesirable reaction or absence of therapeutic effect of the drug (approved by the order of Roszdravnadzor No. 1071 of 15.02.2017).